Factors Contributing to the Use of Traditional-Based Oxytocic Products for Labor Induction and Pregnancy Termination in Rural Settings of Kavango Region, Namibia
Abstract:
The use of traditional oxytocic substances remains widespread in many rural African communities for labor induction and pregnancy termination, despite increasing availability of modern obstetric services. In the Kavango region of Namibia, these practices continue to be commonly utilized and may contribute to adverse maternal health outcomes. A cross-sectional mixed-methods study was conducted among 250 women of reproductive age in rural Kavango. Quantitative data were collected using structured questionnaires and analyzed using SPSS version 26, applying descriptive statistics, chi-square tests, and multivariate logistic regression to identify associated factors. Qualitative data were obtained through focus group discussions and analyzed using thematic analysis. The prevalence of traditional oxytocic use was 62.0% (95% CI: 55.8–68.0). Significant predictors included strong cultural beliefs (AOR = 2.8, p = 0.001), residence more than 10 km from a health facility (AOR = 2.3, p = 0.004), low educational attainment (AOR = 1.9, p = 0.012), and influence of traditional birth attendants (AOR = 3.1, p < 0.001). Reported complications included excessive bleeding (18%), infection (12%), and uterine-related complications (6%). Qualitative findings revealed persistent trust in traditional practices, perceived effectiveness, and concerns about stigma within formal healthcare settings. The study concludes that traditional oxytocic use remains prevalent in rural Kavango and is influenced by socio-cultural dynamics and health system limitations. Interventions should focus on improving healthcare access, strengthening community health education, and fostering collaboration between formal healthcare providers and traditional birth attendants.References:
[1]. World Health Organization. WHO traditional medicine strategy 2014–2023.
Geneva: WHO; 2019.
[2]. World Health Organization. Maternal mortality: key facts. Geneva: WHO;
2023.
[3]. United Nations Population Fund. Maternal Health Thematic Fund annual
report. New York: UNFPA; 2022.
[4]. Ministry of Health and Social Services (Namibia). Namibia demographic
and health survey 2019. Windhoek: MoHSS; 2019.
[5]. UNAIDS. Namibia country report. Geneva: UNAIDS; 2023.
[6]. Campbell OM, Graham WJ. Strategies for reducing maternal mortality:
getting on with what works. Lancet. 2006;368(9543):1284-99.
[7]. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO
systematic analysis. Lancet Glob Health. 2014;2(6):e323-33.
[8]. Filippi V, Ronsmans C, Campbell OM, et al. Maternal
health in poor countries. Lancet. 2006;368:1535-43.
[9]. Thaddeus S, Maine D. Too far to walk: maternal mortality framework. Soc
Sci Med. 1994;38(8):1091-110.
[10]. Bohren MA, Hofmeyr GJ, Sakala C, et al. Continuous support
for women during childbirth. Cochrane Database Syst Rev. 2017.
[11]. Gabrysch S, Campbell OM. Still too far to walk: maternal health service
use. BMC Pregnancy Childbirth. 2009;9:34.
[12]. Mrisho M, Schellenberg JA, Mushi AK, et al. Factors affecting home
delivery in rural Tanzania. Trop Med Int Health. 2007;12(7):862-72.
[13]. Moyer CA, Mustafa A. Drivers and deterrents of facility delivery. Reprod
Health. 2013;10:40.
[14]. Doctor HV, Findley SE, Afenyadu GY, et al. Utilization of maternal
services in sub-Saharan Africa. BMC Pregnancy Childbirth. 2011;11:55.
[15]. Koblinsky M, Matthews Z, Hussein J, et al. Going to scale with
professional skilled care. Lancet. 2006;368:1377-86.
[16]. Sialubanje C, Massar K, Hamer DH, et al. Why do women utilize TBAs? BMC
Pregnancy Childbirth. 2015;15:93.
[17]. Wilson A, Gallos ID, Plana N, et al. Role of traditional birth
attendants. Midwifery. 2011;27(6):e101-7.
[18]. Byrne A, Morgan A. How the integration of TBAs improves maternal
outcomes. Midwifery. 2011;27(6):e219-25.
[19]. Bergström S, Goodburn E. Role of TBAs in developing countries. Lancet.
2001;358:1177-8.
[20]. World Health Organization. WHO recommendations for augmentation of
labour. Geneva: WHO; 2014.
[21]. Hofmeyr GJ, Say L, Gülmezoglu AM. Uterine rupture and oxytocin misuse.
BJOG. 2009;116:1367-70.
[22]. Tsu VD. Antenatal care and safe delivery practices. Int J Gynecol
Obstet. 1994;46:37-45.
[23]. Harrison KA. Maternal mortality in Nigeria. Br J Obstet Gynaecol.
1997;104:22-5.
[24]. AbouZahr C. Global burden of maternal death. Br Med Bull. 2003;67:1-11.
[25]. Ronsmans C, Graham WJ. Maternal mortality: who, when, where. Lancet.
2006;368:1189-200.
[26]. Souza JP, Gülmezoglu AM, Vogel J, et al. Moving
beyond essential interventions. Lancet. 2013;381:1747-55.
[27]. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, et al. Global maternal
mortality trends. Lancet. 2014;384:980-1004.
[28]. Alkema L, Chou D, Hogan D, et al. Global maternal
mortality levels. Lancet. 2016;387:462-74.
[29]. Mgawadere F, Unkels R, Adegoke A, et al. Factors affecting maternal
mortality. BMC Pregnancy Childbirth. 2017;17:389.
[30]. Geleto A, Chojenta C, Musa A, et al. Barriers to maternal health
services. Reprod Health. 2018;15:154.
[31]. Kruk ME, Gage AD, Arsenault C, et al. Quality of maternal healthcare.
Lancet Glob Health. 2018;6:e1196-252.
[32]. Victora CG, Barros AJ, Axelson H, et al. Maternal
and child health in developing countries. Lancet. 2003;362:65-71.
[33]. Bhutta ZA, Das JK, Bahl R, et al. Interventions to
reduce maternal mortality. Lancet. 2014;384:347-70.
[34]. Singh PK, Rai RK, Alagarajan M, et al. Socioeconomic
determinants of maternal health. PLoS One. 2012;7:e44901.
[35]. Fagbamigbe AF, Idemudia ES. Wealth and maternal health service use. BMC
Pregnancy Childbirth. 2015;15:89.
[36]. Gabrysch S, Cousens S, Cox J, et al. Influence of distance on facility
delivery. Trop Med Int Health. 2011;16(7):861-72.
[37]. World Health Organization. Trends in maternal mortality 2000–2020.
Geneva: WHO; 2023.
[38]. United Nations Population Fund. State of the World Population report.
New York: UNFPA; 2022.
[39]. United Nations Children's Fund. Maternal and newborn health statistics.
New York: UNICEF; 2023.
[40]. Lawn JE, Blencowe H, Oza S, et al. Newborn survival.
Lancet. 2014;384:189-205.
[41]. Alhassan AS, Dakurah S, Lasong J. Perspectives of midwives on the use of Kaligutim (local oxytocin) for induction of labour among pregnant women in government hospitals in Tamale. BMC Pregnancy Childbirth. 2024;24(1):561. doi:10.1186/s12884-024-06745-z.
